References
1. Hyder JA, Allison MA, Criqui MH, Wright CM. Association between systemic calcified atherosclerosis and bone density. Calcif Tissue Int 2007;80(5):301–6.
2. Frye MA, Melton LJ 3rd, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, et al. Osteoporosis and calcification of the aorta. Bone Miner 1992;19(2):185–94.
3. Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR. Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 2000;15(10):1974–80.
4. Mussolino ME, Madans JH, Gillum RF. Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 2003;13(10):692–7.
5. Wang PS, Solomon DH, Mogun H, Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000;283(24):3211–6.
6. Parhami F. Possible role of oxidized lipids in osteoporosis: could hyperlipidemia be a risk factor? Prostaglandins Leukot Essent Fatty Acids 2003;68(6):373–8.
7. Parhami F, Garfinkel A, Demer LL. Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol 2000;20(11):2346–8.
8. Tankó LB, Bagger YZ, Nielsen SB, Christiansen C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 2003;32(1):8–14.
9. Colles SM, Maxson JM, Carlson SG, Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med 2001;11(3-4):131–8.
10. Johnston CC Jr, Hui SL, Witt RM, Appledorn R, Baker RS, Longcope C. Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab 1985;61(5):905–11.
11. Rosen CJ, Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009;122(5):409–14.
12. Parhami F, Mody N, Gharavi N, Ballard AJ, Tintut Y, Demer LL. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J Bone Miner Res 2002;17(11):1997–2003.
13. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 1997;17(4):680–7.
14. Buhaescu I, Izzedine H. Mevalonate pathway: a review of clinical and therapeutical implications. Clin Biochem 2007;40(9-10):575–84.
15. Kim YH, Nam GE, Cho KH, Choi YS, Kim SM, Han BD, et al. Low bone mineral density is associated with dyslipidemia in South Korean men: the 2008-2010 Korean National Health and Nutrition Examination Survey. Endocr J 2013;60(10):1179–89.
16. Rhee EJ, Kim SY, Jung CH, Lhee HY, Lee WY, Kim SW. The correlation between lumbar spine bone mineral density and serum lipid profiles in apparently healthy Korean males. J Korean Soc Osteoporosis 2004;2(2):105–11.
17. Suh YS. Relationship between bone mineral density and blood lipid in young and middle-aged men and pre-menopausal women. Korean J Health Promot 2007;7(4):238–44.
18. Solomon DH, Avorn J, Canning CF, Wang PS. Lipid levels and bone mineral density. Am J Med 2005;118(12):1414.
19. Wu LY, Yang TC, Kuo SW, Hsiao CF, Hung YJ, Hsieh CH, et al. Correlation between bone mineral density and plasma lipids in Taiwan. Endocr Res 2003;29(3):317–25.
20. Adami S, Braga V, Zamboni M, Gatti D, Rossini M, Bakri J, et al. Relationship between lipids and bone mass in 2 cohorts of healthy women and men. Calcif Tissue Int 2004;74(2):136–42.
21. Dennison EM, Syddall HE, Aihie Sayer A, Martin HJ, Cooper C. Hertfordshire Cohort Study Group. Lipid profile, obesity and bone mineral density: the Hertfordshire Cohort Study. QJM 2007;100(5):297–303.
22. Hernández JL, Olmos JM, Ramos C, Martínez J, de Juan J, Valero C, et al. Serum lipids and bone metabolism in Spanish men: the Camargo cohort study. Endocr J 2010;57(1):51–60.
23. Adami S, Braga V, Gatti D. Association between bone mineral density and serum lipids in men. JAMA 2001;286(7):791–2.
24. Cui LH, Shin MH, Chung EK, Lee YH, Kweon SS, Park KS, et al. Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea. Osteoporos Int 2005;16(12):1975–81.
25. Zhao LJ, Liu YJ, Liu PY, Hamilton J, Recker RR, Deng HW. Relationship of obesity with osteoporosis. J Clin Endocrinol Metab 2007;92(5):1640–6.
26. Lenchik L, Register TC, Hsu FC, Lohman K, Nicklas BJ, Freedman BI, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003;33(4):646–51.
27. Maurin AC, Chavassieux PM, Frappart L, Delmas PD, Serre CM, Meunier PJ. Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone 2000;26(5):485–9.
28. Dragojevič J, Zupan J, Haring G, Herman S, Komadina R, Marc J. Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study. J Bone Miner Metab 2013;31(5):512–9.
29. D'Amelio P, Pescarmona GP, Gariboldi A, Isaia GC. High density lipoproteins (HDL) in women with postmenopausal osteoporosis: a preliminary study. Menopause 2001;8(6):429–32.
30. Yamaguchi T, Sugimoto T, Yano S, Yamauchi M, Sowa H, Chen Q, et al. Plasma lipids and osteoporosis in postmenopausal women. Endocr J 2002;49(2):211–7.